ClinicalThought

Share

Program Content

Activities

  • PARPi in Ovarian Cancer
    How I Am Using PARP Inhibitors in the Care of Patients With Ovarian Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 02, 2019

    Expires: April 30, 2020

  • ASCO 2019 Data on PARPi
    PARP Inhibitors in Recurrent Ovarian Cancer: What’s New at ASCO 2019
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2019

    Expires: June 22, 2020

  • PARPi Dosing and Safety
    Dosing and Safety of PARP Inhibitors in Ovarian Cancer: Tips From My Clinic
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 27, 2019

    Expires: August 25, 2020

  • QUADRA Trial Implications
    My Thoughts on the Clinical Implications of the Expanded Indication for Niraparib
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 26, 2019

    Expires: November 24, 2020

Provided by

ProCE Banner

Supporters

Clovis Oncology

Tesaro